Antibacterial activities of hexadecanoic acid methyl ester and green-synthesized silver nanoparticles against multidrug-resistant bacteria
- PMID: 33871873
- DOI: 10.1002/jobm.202100061
Antibacterial activities of hexadecanoic acid methyl ester and green-synthesized silver nanoparticles against multidrug-resistant bacteria
Abstract
Antibacterial drug resistance is considered one of the biggest threats to human health worldwide, and the overuse of antibiotics accelerates this problem. Multidrug-resistant (MDR) bacteria are becoming harder to treat as the antibiotics used to treat them become less effective. Therefore, it is necessary to evaluate novel methods to control MDR bacteria. In this study, 40 bacterial isolates were collected from diabetic patients. The sensitivity of 40 bacterial isolates to seven antibiotics was evaluated. Four bacterial isolates were resistant to all antibiotic groups. The MDR pathogenic bacteria were selected and identified morphologically and biochemically and confirmed by VITEK® 2 system as follows: Staphylococcus aureus W35, Pseudomonas aeruginosa D31, Klebsiella pneumoniae DF30, and K. pneumoniae B40. Identification of the most resistant P. aeruginosa D31 was confirmed by the sequencing of a 16S ribosomal RNA gene with an accession number (MW241596). The inhibitory activity of eight types of native grown plant extracts against MDR bacteria was studied. Clove alcoholic extract (CAE) showed the highest inhibitory activity against MDR bacteria. Gas chromatography-mass spectrometry analysis of partially purified CAE at 0.9 Rf detected by thin-layer chromatography showed an active compound named hexadecenoic acid methyl ester with the highest antimicrobial effect against clinical pathogenic bacteria. The formation of silver nanoparticles (AgNPs) by CAE was studied. Evaluation of AgNPs was investigated by X-ray diffraction, UV-Vis, and transmission electron microscopy. The antibacterial effect of AgNPs after 2, 4, and 6 days in light and dark conditions was evaluated. Finally, the AgNPs synthesized using CAE possess good inhibition activity against the tested pathogenic bacteria. As a result, the bactericidal components listed above were promising in reducing MDR bacteria and can be used for treatments of bacterial infection and in the development of safe products with a natural base.
Keywords: antibacterial activities; hexadecanoic acid methyl ester; multidrug-resistant bacteria; silver nanoparticles.
© 2021 Wiley-VCH GmbH.
Similar articles
-
Antibacterial, antibiofilm, and antiquorum sensing activities of phytosynthesized silver nanoparticles fabricated from Mespilus germanica extract against multidrug resistance of Klebsiella pneumoniae clinical strains.J Basic Microbiol. 2020 Mar;60(3):216-230. doi: 10.1002/jobm.201900511. Epub 2020 Jan 29. J Basic Microbiol. 2020. PMID: 31994223
-
Implementation of Silver Nanoparticles Green Synthesized with Leaf Extract of Coccinia grandis as Antimicrobial Agents Against Head and Neck Infection MDR Pathogens.Curr Pharm Biotechnol. 2024;25(17):2312-2325. doi: 10.2174/0113892010290653240109053852. Curr Pharm Biotechnol. 2024. PMID: 38347796
-
Green synthesis of silver nanoparticles using Sudanese Candida parapsilosis: a sustainable approach to combat antimicrobial resistance.BMC Microbiol. 2025 May 21;25(1):312. doi: 10.1186/s12866-025-04038-9. BMC Microbiol. 2025. PMID: 40399773 Free PMC article.
-
Antibacterial and antibiofilm potential of silver nanoparticles against antibiotic-sensitive and multidrug-resistant Pseudomonas aeruginosa strains.Braz J Microbiol. 2021 Mar;52(1):267-278. doi: 10.1007/s42770-020-00406-x. Epub 2020 Nov 24. Braz J Microbiol. 2021. PMID: 33231865 Free PMC article. Review.
-
Nanocomposites: silver nanoparticles and bacteriocins obtained from lactic acid bacteria against multidrug-resistant Escherichia coli and Staphylococcus aureus.World J Microbiol Biotechnol. 2024 Oct 3;40(11):341. doi: 10.1007/s11274-024-04151-3. World J Microbiol Biotechnol. 2024. PMID: 39358621 Review.
Cited by
-
Chemico-pharmacological evaluation of the methanolic leaf extract of Catharanthus ovalis: GC-MS/MS, in vivo, in vitro, and in silico approaches.Front Pharmacol. 2024 Mar 1;15:1347069. doi: 10.3389/fphar.2024.1347069. eCollection 2024. Front Pharmacol. 2024. PMID: 38495091 Free PMC article.
-
Assessing the efficacy of probiotics in augmenting bovine reproductive health: an integrated in vitro, in silico, and in vivo study.Front Microbiol. 2023 May 18;14:1137611. doi: 10.3389/fmicb.2023.1137611. eCollection 2023. Front Microbiol. 2023. PMID: 37275132 Free PMC article.
-
Multidrug-resistant organism-peritoneal dialysis associated peritonitis: clinical and microbiological features and risk factors of treatment failure.Front Med (Lausanne). 2023 May 10;10:1132695. doi: 10.3389/fmed.2023.1132695. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37234246 Free PMC article.
-
Phyto-pharmacological evaluation and characterization of the methanolic extract of the Baccaurea motleyana Müll. Arg. seed: promising insights into its therapeutic uses.Front Pharmacol. 2024 Feb 29;15:1359815. doi: 10.3389/fphar.2024.1359815. eCollection 2024. Front Pharmacol. 2024. PMID: 38487168 Free PMC article.
-
Therapeutic potential of green-synthesized silver nanoparticles: Combating biofilms of multidrug-resistant Staphylococcus aureus RM-Ph8 and modulating the immune response in the liver tissue of rats.Vet World. 2024 Oct;17(10):2211-2224. doi: 10.14202/vetworld.2024.2211-2224. Epub 2024 Oct 4. Vet World. 2024. PMID: 39619935 Free PMC article.
References
REFERENCES
-
- Chandra H, Bishnoi P, Yadav A, Patni B, Mishra AB, Nautiyal AR. Antimicrobial resistance and the alternative resources with special emphasis on plant-based antimicrobials-a review. Plants (Basel). 2017;6:16.
-
- Enan G, Al-Mohammadi AR, Mahgoub S, Abdel-Shafi S, Askar E, Ghaly MF, et al. Inhibition of Staphylococcus aureus LC554891 by Moringa oleifera seed extract either singly or in combination with antibiotics. Molecules. 2020;10:4583.
-
- Bassetti M, Vena A, Croxatto A, Righi E, Guery B. How to manage Pseudomonas aeruginosa infections. Drugs Context. 2018;7:212-527.
-
- Laxminarayan R, Duse A, Wattal C, Zaidi AKM, Wertheim HFL, Sumpradit N, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13:1057-98.
-
- Shakya AK. Medicinal plants: future source of new drugs. Int J Herb Med. 2016;4:59-64.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials